Elizabeth Laws

Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts

Surya P. Bhatt, Klaus F. Rabe, Nicola A. Hanania et al. · New England Journal of Medicine · 2023 · 458 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis

Evan S. Dellon, Marc E. Rothenberg, Margaret H. Collins et al. · New England Journal of Medicine · 2022 · 456 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

Amy S. Paller, Eric L. Simpson, Elaine C. Siegfried et al. · The Lancet · 2022 · 264 citations · Full text

Medicine, Dermatology, Pediatrics +10

Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation

Surya P. Bhatt, Klaus F. Rabe, Nicola A. Hanania et al. · New England Journal of Medicine · 2024 · 245 citations

Life Sciences, Immunology, Pharmacotherapy +17

Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis

Michael E. Wechsler, Amy D. Klion, Pierluigi Paggiaro et al. · The Journal of Allergy and Clinical Immunology In Practice · 2022 · 229 citations · Full text

Medicine, Immunology, Pharmacology +17